APA (7th ed.) Citation

Gong, H., Tian, S., Ding, H., Tao, L., Wang, L., Wang, J., . . . Zhou, L. (2024). Author Correction: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial. Nature communications, 15(1), 1. https://doi.org/10.1038/s41467-024-51057-7

Chicago Style (17th ed.) Citation

Gong, Hongli, et al. "Author Correction: Camrelizumab-based Induction Chemoimmunotherapy in Locally Advanced Stage Hypopharyngeal Carcinoma: Phase II Clinical Trial." Nature Communications 15, no. 1 (2024): 1. https://doi.org/10.1038/s41467-024-51057-7.

MLA (9th ed.) Citation

Gong, Hongli, et al. "Author Correction: Camrelizumab-based Induction Chemoimmunotherapy in Locally Advanced Stage Hypopharyngeal Carcinoma: Phase II Clinical Trial." Nature Communications, vol. 15, no. 1, 2024, p. 1, https://doi.org/10.1038/s41467-024-51057-7.